Catalyst Event
Alnylam Pharmaceuticals Inc (ALNY) · Earnings Release
From KEDI Nvidia Fixed Tech100 Index (KNVDT100)
4/30/2026, 12:00:00 AM
Alnylam Pharmaceuticals reported Q1 2026 financial results, with EPS of $1.99 beating analyst estimates of $0.91 and revenue of $1.17 billion exceeding forecasts of $1.12 billion. The company achieved its first-ever quarter with over $1 billion in net product revenues. High importance is estimated due to the significant EPS beat and milestone revenue.
Korean Translation
앨나일람 파마슈티컬스는 2026년 1분기 재무 실적을 발표했으며, 주당 순이익(EPS)은 1.99달러로 분석가 예상치인 0.91달러를 상회했고, 매출은 11억 7천만 달러로 예상치인 11억 2천만 달러를 초과함. 회사는 사상 처음으로 분기 순제품 매출 10억 달러를 돌파함. 큰 폭의 EPS 상회 및 매출 이정표 달성으로 인해 높은 중요도로 예상됨.
Related Recent Events
Telefonaktiebolaget LM Ericsson (publ) (ERIC) · Earnings Release
Q3 2026 earnings release scheduled.
10/15/2026, 12:00:00 AM
ASML Holding NV (ASML) · Earnings Release
ASML is scheduled to release its Q2 2026 financial results on 2026-07-15. The company guided for Q2 sales between €8.4 billion and €9.0 billion, with an estimated price impact of ≥5%, scheduled.
7/15/2026, 12:00:00 AM
Telefonaktiebolaget LM Ericsson (publ) (ERIC) · Earnings Release
Q2 2026 earnings release scheduled.
7/14/2026, 12:00:00 AM
CrowdStrike Holdings Inc (CRWD) · Other
2026 Annual Meeting of Stockholders to be held virtually on 2026-06-17. Medium importance due to ≥5% price impact scheduled.
6/17/2026, 12:00:00 AM
Adobe Inc (ADBE) · Earnings Release
Adobe's Q2 2026 earnings release, which typically results in a medium price impact of 5%, is scheduled.
6/11/2026, 12:00:00 AM
CrowdStrike Holdings Inc (CRWD) · Earnings Release
Q1 fiscal 2027 earnings release scheduled for 2026-06-09. Analysts forecast EPS of $1.07. Low importance due to ≥1% price impact forecasted.
6/9/2026, 12:00:00 AM